Clinical Trial Update: MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue [NA]

View source ↗

Summary

A clinical trial evaluating molecular breast imaging (MBI) and breast tomosynthesis for screening in women with dense breast tissue has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Snippet

Sponsor: Gamma Medica, Inc. | Conditions: Breast Neoplasms | NA | Status: WITHDRAWN